Does CARFILZOMIB Cause Mucosal inflammation? 88 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Mucosal inflammation have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.4% of all adverse event reports for CARFILZOMIB.
88
Reports of Mucosal inflammation with CARFILZOMIB
0.4%
of all CARFILZOMIB reports
13
Deaths
34
Hospitalizations
How Dangerous Is Mucosal inflammation From CARFILZOMIB?
Of the 88 reports, 13 (14.8%) resulted in death, 34 (38.6%) required hospitalization, and 17 (19.3%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 88 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which CARFILZOMIB Alternatives Have Lower Mucosal inflammation Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL